Abstract
We recently performed a laparoscopic cholecystectomy on three patients receiving preoperative oral anticoagulant therapy. The patients requiring anticoagulants for pre-existing cardiac conditions have the following risks at surgery: thromboembolism, hemorrhage, endocarditis, and cardiopulmonary dysfunction. In patients receiving anticoagulant therapy, one must thus maintain a balanced international normalized ratio of the prothrombin time to prevent thromboembolism or hemorrhage. Warfarin sodium was discontinued preoperatively in all patients. Heparin sodium was individualized according to each patient’s risk of thromboembolism. As a result, these patients all underwent a laparoscopic cholecystectomy without complications. Attention was paid to achieve hemostasis in the operative field and the trocar inserted sites during the procedure. The administration of warfarin sodium was resumed on the first postoperative day in all patients. Restarting warfarin sodium early also helps to simplify postoperative management. A broad spectrum of antibiotic therapy was also used to reduce the risk of endocarditis. Each patient’s cardiopulmonary function was carefully monitored. The minimal invasion experienced during a laparoscopic cholecystectomy may thus facilitate the management of gallstones in patients receiving systemic anticoagulation treatment based on the findings of this limited series.
Similar content being viewed by others
References
Kitano S, Sugimachi K (1993) Peritoneoscopic cholecystectomy has opened the door to minimally invasive surgery. J Gastroenterol Hapatol 8:476–482
Fitzgerald SD, Bailey PV, Liebscher GJ, Andrus CH (1991) Laparoscopic cholecystectomy in anticoagulated patients. Surg Endosc 5:166–169
Kitano S, Iso Y, Moriyama M, Sugimachi K (1992) A newly designed single dissector useful for laparoscopic cholecystectomy. Surg Endosc 6:144–146
Poller L (1987) Laboratory control of oral anticoagulants. Br Med J 294:1184
Travis S, Wray R, Harrison K (1989) Perioperative anticoagulant control. Br J Surg 76:1107–1108
Kosuga K, Aoyagi S, Shima H, Yanagi I, Oryoji A, Oishi K, Koga M (1987) Surgery for patients on anticoagulants following prosthetic valve replacement (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (Jpn J Surg) 88:779–784
Shimada M, Matsumata T, Taketomi A, Nishizaki T, Itasaka H, Sugimachi K (1994) Major hepatic resection in patients with a prosthetic heart valve receiving anticoagulation treatment. Hepato-Gastroenterol 41:290–293
Durack DT (1992) Infective endocarditis. In: Wyngaarden JB, Smith Jr LH, Bennett JC (eds) Cecil textbook of medicine. WB Saunders, Philadelphia, pp 1638–1647
National Institutes of Health (1986) Prevention of venous thrombosis and pulmonary embolism. J Am Med Assoc 256:744–749
Wittgen CM, Andrus CH, Fitzgerald SD, Baudendistel LJ, Dahms TE, Kaminski DL (1991) Analysis of the hemodynamic and ventilatory effects of laparoscopic cholecystectomy. Arch Surg 126:997–1001
Harrison EC, Roschke EJ, Meyers HI, Edmiston WA, Chan LS, Tatter D, Lau FY (1978) Cholelithiasis: a frequent complication of artificial heart valve replacement. Am Heart J 95:483–488
Yokote M, Yokote M, Takikawa H, Yamanaka M (1993) Diseases with high incidence of gallstone complication (in Japanese with English abstract). Nippon Rhinsho (Jpn J Clin Med) 51:1744–1750
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshida, T., Kitano, S., Matsumoto, T. et al. Laparoscopic cholecystectomy in patients undergoing anticoagulant therapy. Surg Today 28, 308–312 (1998). https://doi.org/10.1007/s005950050128
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950050128